EDAP TMS SA (EDAP) - Net Assets
Based on the latest financial reports, EDAP TMS SA (EDAP) has net assets worth $19.41 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($79.00 Million) and total liabilities ($59.58 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how resilient are EDAP TMS SA's assets to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $19.41 Million |
| % of Total Assets | 24.57% |
| Annual Growth Rate | -1.96% |
| 5-Year Change | -61.22% |
| 10-Year Change | -20.6% |
| Growth Volatility | 40.11 |
EDAP TMS SA - Net Assets Trend (1997–2025)
This chart illustrates how EDAP TMS SA's net assets have evolved over time, based on quarterly financial data. Also explore EDAP total assets for the complete picture of this company's asset base.
Annual Net Assets for EDAP TMS SA (1997–2025)
The table below shows the annual net assets of EDAP TMS SA from 1997 to 2025. For live valuation and market cap data, see market cap of EDAP TMS SA.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $19.41 Million | -52.53% |
| 2024-12-31 | $40.90 Million | -28.16% |
| 2023-12-31 | $56.92 Million | -20.53% |
| 2022-12-31 | $71.63 Million | +43.10% |
| 2021-12-31 | $50.05 Million | +90.70% |
| 2020-12-31 | $26.25 Million | -4.06% |
| 2019-12-31 | $27.36 Million | +9.59% |
| 2018-12-31 | $24.96 Million | -0.77% |
| 2017-12-31 | $25.16 Million | +2.89% |
| 2016-12-31 | $24.45 Million | +69.45% |
| 2015-12-31 | $14.43 Million | -4.70% |
| 2014-12-31 | $15.14 Million | +63.09% |
| 2013-12-31 | $9.28 Million | +13.76% |
| 2012-12-31 | $8.16 Million | -6.34% |
| 2011-12-31 | $8.71 Million | -2.10% |
| 2010-12-31 | $8.90 Million | -29.25% |
| 2009-12-31 | $12.58 Million | -26.83% |
| 2008-12-31 | $17.19 Million | +18.38% |
| 2007-12-31 | $14.52 Million | -24.76% |
| 2006-12-31 | $19.30 Million | +11.18% |
| 2005-12-31 | $17.36 Million | -3.30% |
| 2004-12-31 | $17.95 Million | -5.16% |
| 2003-12-31 | $18.93 Million | -33.35% |
| 2002-12-31 | $28.40 Million | -27.14% |
| 2001-12-31 | $38.98 Million | +12.08% |
| 2000-12-31 | $34.78 Million | +124.80% |
| 1999-12-31 | $15.47 Million | -37.87% |
| 1998-12-31 | $24.90 Million | -26.38% |
| 1997-12-31 | $33.82 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to EDAP TMS SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 867.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $5.17 Million | 26.62% |
| Other Comprehensive Income | $-7.10 Million | -36.55% |
| Other Components | $130.81 Million | 673.81% |
| Total Equity | $19.41 Million | 100.00% |
EDAP TMS SA Competitors by Market Cap
The table below lists competitors of EDAP TMS SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
BHMINESLTD FPO [BHM]
AU:BHM
|
$126.42 Million |
|
Showbox Corp
KQ:086980
|
$126.44 Million |
|
Info-Tek
TWO:8183
|
$126.49 Million |
|
Yao Sheng Electronic Co Ltd
TWO:3207
|
$126.50 Million |
|
TON Strategy Co
NASDAQ:TONX
|
$126.26 Million |
|
China National Accord Medicines Corp Ltd
SHE:200028
|
$126.15 Million |
|
Bank Negara Indonesia Tbk
JK:BBNI
|
$126.14 Million |
|
Rav Bariach 08 Industries Ltd
TA:BRIH
|
$126.09 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in EDAP TMS SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 40,896,000 to 19,413,000, a change of -21,483,000 (-52.5%).
- Net loss of 29,336,493 reduced equity.
- Other comprehensive income decreased equity by 2,201,621.
- Other factors increased equity by 10,055,114.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-29.34 Million | -151.12% |
| Other Comprehensive Income | $-2.20 Million | -11.34% |
| Other Changes | $10.06 Million | +51.8% |
| Total Change | $- | -52.53% |
Book Value vs Market Value Analysis
This analysis compares EDAP TMS SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 6.69x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.68x to 6.69x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1997-12-31 | $5.07 | $3.47 | x |
| 1998-12-31 | $2.99 | $3.47 | x |
| 1999-12-31 | $1.98 | $3.47 | x |
| 2000-12-31 | $4.21 | $3.47 | x |
| 2001-12-31 | $4.91 | $3.47 | x |
| 2002-12-31 | $3.63 | $3.47 | x |
| 2003-12-31 | $2.42 | $3.47 | x |
| 2004-12-31 | $2.22 | $3.47 | x |
| 2005-12-31 | $2.07 | $3.47 | x |
| 2006-12-31 | $2.02 | $3.47 | x |
| 2007-12-31 | $1.58 | $3.47 | x |
| 2008-12-31 | $1.78 | $3.47 | x |
| 2009-12-31 | $1.19 | $3.47 | x |
| 2010-12-31 | $0.68 | $3.47 | x |
| 2011-12-31 | $0.65 | $3.47 | x |
| 2012-12-31 | $0.46 | $3.47 | x |
| 2013-12-31 | $0.45 | $3.47 | x |
| 2014-12-31 | $0.64 | $3.47 | x |
| 2015-12-31 | $0.58 | $3.47 | x |
| 2016-12-31 | $0.83 | $3.47 | x |
| 2017-12-31 | $0.87 | $3.47 | x |
| 2018-12-31 | $0.86 | $3.47 | x |
| 2019-12-31 | $0.92 | $3.47 | x |
| 2020-12-31 | $0.90 | $3.47 | x |
| 2021-12-31 | $1.54 | $3.47 | x |
| 2022-12-31 | $2.08 | $3.47 | x |
| 2023-12-31 | $1.54 | $3.47 | x |
| 2024-12-31 | $1.10 | $3.47 | x |
| 2025-12-31 | $0.52 | $3.47 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently EDAP TMS SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -151.12%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -41.47%
- • Asset Turnover: 0.90x
- • Equity Multiplier: 4.07x
- Recent ROE (-151.12%) is below the historical average (-25.50%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1997 | 0.54% | 0.56% | 0.64x | 1.51x | $-3.20 Million |
| 1998 | -28.77% | -30.88% | 0.51x | 1.82x | $-9.65 Million |
| 1999 | -40.40% | -32.61% | 0.53x | 2.36x | $-7.80 Million |
| 2000 | 33.77% | 42.97% | 0.54x | 1.45x | $8.26 Million |
| 2001 | 18.34% | 29.78% | 0.45x | 1.37x | $3.25 Million |
| 2002 | -14.24% | -20.24% | 0.50x | 1.40x | $-6.88 Million |
| 2003 | -47.34% | -48.59% | 0.58x | 1.68x | $-10.85 Million |
| 2004 | -6.39% | -5.18% | 0.79x | 1.55x | $-2.94 Million |
| 2005 | -6.13% | -5.12% | 0.72x | 1.66x | $-2.80 Million |
| 2006 | -17.78% | -16.93% | 0.62x | 1.68x | $-5.36 Million |
| 2007 | -37.45% | -24.32% | 0.50x | 3.10x | $-6.89 Million |
| 2008 | 9.29% | 6.93% | 0.53x | 2.55x | $-122.10K |
| 2009 | -61.74% | -31.21% | 0.62x | 3.21x | $-9.02 Million |
| 2010 | -142.89% | -53.64% | 0.66x | 4.04x | $-13.61 Million |
| 2011 | -10.77% | -4.21% | 0.68x | 3.74x | $-1.81 Million |
| 2012 | -91.59% | -28.68% | 0.86x | 3.73x | $-8.29 Million |
| 2013 | -54.08% | -20.85% | 0.90x | 2.89x | $-5.95 Million |
| 2014 | -3.38% | -1.91% | 0.83x | 2.12x | $-2.03 Million |
| 2015 | -11.55% | -5.17% | 0.84x | 2.67x | $-3.11 Million |
| 2016 | 15.71% | 10.79% | 0.76x | 1.91x | $1.40 Million |
| 2017 | -2.71% | -1.91% | 0.76x | 1.86x | $-3.20 Million |
| 2018 | -1.35% | -0.86% | 0.80x | 1.95x | $-2.83 Million |
| 2019 | 5.53% | 3.37% | 0.85x | 1.94x | $-1.22 Million |
| 2020 | -6.49% | -4.09% | 0.75x | 2.10x | $-4.33 Million |
| 2021 | 1.40% | 1.59% | 0.57x | 1.54x | $-4.31 Million |
| 2022 | -4.09% | -5.32% | 0.54x | 1.41x | $-10.10 Million |
| 2023 | -37.20% | -35.05% | 0.66x | 1.61x | $-26.87 Million |
| 2024 | -46.50% | -29.66% | 0.74x | 2.10x | $-23.11 Million |
| 2025 | -151.12% | -41.47% | 0.90x | 4.07x | $-31.28 Million |
Industry Comparison
This section compares EDAP TMS SA's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $1,190,389,579
- Average return on equity (ROE) among peers: -8.81%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| EDAP TMS SA (EDAP) | $19.41 Million | 0.54% | 3.07x | $126.31 Million |
| Accendra Health Inc (ACH) | $565.23 Million | -64.17% | 7.24x | $147.73 Million |
| Akso Health Group ADR (AHG) | $17.27 Million | -201.64% | 0.83x | $807.33 Million |
| Cardinal Health Inc (CAH) | $54.00 Million | 12.22% | 2.53x | $45.94 Billion |
| Cencora Inc. (COR) | $75.30 Million | 67.07% | 19.61x | $59.14 Billion |
| Cosmos Health Inc. (COSM) | $-53.68K | 0.00% | 0.00x | $10.83 Million |
| Empro Group Inc. Ordinary shares (EMPG) | $1.41 Million | 82.70% | 1.73x | $143.05 Million |
| Henry Schein Inc (HSIC) | $3.66 Billion | 0.00% | 1.14x | $8.70 Billion |
| McKesson Corporation (MCK) | $6.27 Billion | 15.35% | 2.82x | $99.71 Billion |
| Owens & Minor Inc (OMI) | $70.80 Million | 9.18% | 1.18x | $185.63 Million |
About EDAP TMS SA
EDAP TMS S.A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU s… Read more